RFK Jr. eases access to unproven peptides despite opposition from FDA scientists
Katherine Langford
Katherine Langford
Editor-in-Chief · Edina, MN
Katherine oversees editorial operations across all six brands. Before joining The Meridan Group, she spent 14 years at the Minneapolis Star Tribune, where she led the metro desk through its digital transformation. She holds a Master's in Journalism from Northwestern's Medill School.
More from Katherine →Editor-in-Chief · Thursday, October 29, 2026 at 5:13 PM · 1 min read
Under normal FDA rules, those chemicals would be considered illegal drugs because they have not gone through the agency’s rigorous review process for safety and effectiveness.